Phosphodiesterase-5 Inhibitors and Colorectal Cancer: A New Frontier for Prevention?

Gastroenterology - United Kingdom
doi 10.1053/j.gastro.2019.07.017
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Daily Use of Phosphodiesterase Type 5 Inhibitors as Prevention for Recurrent Priapism

Revista da Associacao Medica Brasileira
Medicine
2017English

Phosphodiesterase-5 Inhibitors: Emerging Nephroprotective Drugs

Anatolian journal of cardiology
Cardiovascular MedicineCardiology
2015English

Phosphodiesterase Type 5 Inhibitors: A Biochemical and Clinical Correlation Survey

International Journal of Impotence Research
Urology
2003English

AB030. Evolution of Phosphodiesterase Type 5 Inhibitors

Translational Andrology and Urology
Reproductive MedicineUrology
2016English

Pharmacological and Dietary Prevention for Colorectal Cancer

BMC Surgery
MedicineSurgery
2013English

Accident Prevention as the "New Frontier"

Clinical Pediatrics
Child HealthPediatricsPerinatology
1967English

Phenanthrenes From Eulophia Macrobulbon as Novel Phosphodiesterase-5 Inhibitors

Natural Product Communications
PharmacologyComplementaryPlant ScienceAlternative MedicineMedicineDrug Discovery
2017English

Cancer Therapy Combination: Green Tea and a Phosphodiesterase 5 Inhibitor?

Journal of Clinical Investigation
Medicine
2013English

Aspirin for the Prevention of Colorectal Cancer

Best Practice and Research in Clinical Gastroenterology
Gastroenterology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy